The Nephrotic Syndrome Gene Panel by NGS analyzes genes associated with hereditary forms of nephrotic syndrome and related kidney disorders. Metropolis Healthcare uses advanced sequencing on an EDTA blood sample to detect mutations that affect kidney filtration and protein regulation. This test helps determine the underlying cause, guide treatment decisions, and predict disease progression. It is valuable for patients with early-onset, steroid-resistant, or recurrent kidney disease
Price:
Rs. 20,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0334
Frequently Asked Questions (FAQ's):
What does the Nephrotic Syndrome Gene Panel include?
It includes comprehensive analysis of genes linked to hereditary nephrotic syndrome, proteinuria, and glomerular dysfunction.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-precision Next-Generation Sequencing (NGS) to evaluate multiple kidney-related genes from an EDTA blood sample.
Who should take this test?
Patients with early-onset nephrotic syndrome, steroid-resistant cases, familial kidney disease, or recurrent symptoms after transplant may benefit.
Why is genetic testing important for nephrotic syndrome?
It helps identify the exact genetic cause, predict treatment response, and guide long-term disease management.
Can this test assist in treatment planning?
Yes, results can support decisions on steroid therapy, immunosuppression, and transplant suitability.
How reliable are the results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality controls and uses validated NGS platforms to ensure high accuracy.
Does this test help with family counselling?
Genetic findings can clarify inheritance patterns and support risk assessment for family members.
How long does the test take to process?
Metropolis Healthcare typically provides results within the standard reporting period for NGS-based gene panels